These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 29109785)

  • 1. Overexpression of miR-194 Reverses HMGA2-driven Signatures in Colorectal Cancer.
    Chang HY; Ye SP; Pan SL; Kuo TT; Liu BC; Chen YL; Huang TC
    Theranostics; 2017; 7(16):3889-3900. PubMed ID: 29109785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancer.
    Mansoori B; Mohammadi A; Naghizadeh S; Gjerstorff M; Shanehbandi D; Shirjang S; Najafi S; Holmskov U; Khaze V; Duijf PHG; Baradaran B
    J Cell Physiol; 2020 Feb; 235(2):920-931. PubMed ID: 31241772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53-induced miR-1249 inhibits tumor growth, metastasis, and angiogenesis by targeting VEGFA and HMGA2.
    Chen X; Zeng K; Xu M; Liu X; Hu X; Xu T; He B; Pan Y; Sun H; Wang S
    Cell Death Dis; 2019 Feb; 10(2):131. PubMed ID: 30755600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-4500 is epigenetically downregulated in colorectal cancer and functions as a novel tumor suppressor by regulating HMGA2.
    Yu FY; Tu Y; Deng Y; Guo C; Ning J; Zhu Y; Lv X; Ye H
    Cancer Biol Ther; 2016 Nov; 17(11):1149-1157. PubMed ID: 27686621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
    Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
    Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-543 suppresses colorectal cancer growth and metastasis by targeting KRAS, MTA1 and HMGA2.
    Fan C; Lin Y; Mao Y; Huang Z; Liu AY; Ma H; Yu D; Maitikabili A; Xiao H; Zhang C; Liu F; Luo Q; Ouyang G
    Oncotarget; 2016 Apr; 7(16):21825-39. PubMed ID: 26968810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular RNA 100146 Promotes Colorectal Cancer Progression by the MicroRNA 149/HMGA2 Axis.
    Liu K; Mou Y; Shi X; Liu T; Chen Z; Zuo X
    Mol Cell Biol; 2021 Jan; 41(2):. PubMed ID: 33257506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-363-3p inhibits the epithelial-to-mesenchymal transition and suppresses metastasis in colorectal cancer by targeting Sox4.
    Hu F; Min J; Cao X; Liu L; Ge Z; Hu J; Li X
    Biochem Biophys Res Commun; 2016 May; 474(1):35-42. PubMed ID: 27084453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-302a-5p/367-3p-HMGA2 axis regulates malignant processes during endometrial cancer development.
    Ma J; Li D; Kong FF; Yang D; Yang H; Ma XX
    J Exp Clin Cancer Res; 2018 Feb; 37(1):19. PubMed ID: 29391048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
    Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
    Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-98-HMGA2-POSTN signal pathway reverses epithelial-to-mesenchymal transition in laryngeal squamous cell carcinoma.
    Zhu M; Zhang C; Chen D; Chen S; Zheng H
    Biomed Pharmacother; 2019 Sep; 117():108998. PubMed ID: 31207579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling.
    Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L
    Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of long noncoding RNA CRNDE suppresses drug resistance of liver cancer cells by increasing microRNA-33a expression and decreasing HMGA2 expression.
    Han S; Han B; Li Z; Sun D
    Cell Cycle; 2019 Oct; 18(19):2524-2537. PubMed ID: 31416393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-219-5p inhibits growth and metastasis of ovarian cancer cells by targeting HMGA2.
    Xing F; Song Z; He Y
    Biol Res; 2018 Nov; 51(1):50. PubMed ID: 30474570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
    Tao Y; Han T; Zhang T; Ma C; Sun C
    Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
    Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
    BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-26a acts as a tumor suppressor inhibiting gallbladder cancer cell proliferation by directly targeting HMGA2.
    Zhou H; Guo W; Zhao Y; Wang Y; Zha R; Ding J; Liang L; Hu J; Shen H; Chen Z; Yin B; Ma B
    Int J Oncol; 2014 Jun; 44(6):2050-8. PubMed ID: 24682444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine.
    Liu M; Xu A; Yuan X; Zhang Q; Fang T; Wang W; Li C
    J Transl Med; 2015 Jun; 13():195. PubMed ID: 26084278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-495 Inhibits Gastric Cancer Cell Migration and Invasion Possibly via Targeting High Mobility Group AT-Hook 2 (HMGA2).
    Wang H; Jiang Z; Chen H; Wu X; Xiang J; Peng J
    Med Sci Monit; 2017 Feb; 23():640-648. PubMed ID: 28159956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.